Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study

[1]  S. Cho,et al.  Low testosterone level is an independent risk factor for high‐grade prostate cancer detection at biopsy , 2016, BJU international.

[2]  O. Burschtin,et al.  Testosterone Deficiency and Sleep Apnea. , 2016, The Urologic clinics of North America.

[3]  K. Krysta,et al.  Effects of hormones on cognition in schizophrenic male patients--preliminary results. , 2015, Psychiatria Danubina.

[4]  D. Berlowitz,et al.  Ascertainment of Testosterone Prescribing Practices in the VA , 2015, Medical care.

[5]  David Handelsman.  Irrational Exuberance in Testosterone Prescribing: When Will the Bubble Burst? , 2015, Medical care.

[6]  S. Grover,et al.  Sexual Dysfunction in Patients with Alcohol and Opioid Dependence , 2014, Indian journal of psychological medicine.

[7]  J. Dartigues,et al.  Low testosterone and the risk of dementia in elderly men: Impact of age and education , 2014, Alzheimer's & Dementia.

[8]  S. Greenland,et al.  Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men , 2014, PloS one.

[9]  M. Grossmann,et al.  Lowered testosterone in male obesity: mechanisms, morbidity and management , 2014, Asian journal of andrology.

[10]  J. B. Layton,et al.  Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  G. Grunwald,et al.  Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. , 2013, JAMA.

[12]  D. Carpenter,et al.  Hypogonadism in Men With Chronic Pain Linked to the Use of Long-acting Rather Than Short-acting Opioids , 2013, The Clinical journal of pain.

[13]  M. Weiner,et al.  Exploration of ICD-9-CM coding of chronic disease within the Elixhauser Comorbidity Measure in patients with chronic heart failure. , 2013, Perspectives in health information management.

[14]  J. Goodwin,et al.  Trends in androgen prescribing in the United States, 2001 to 2011. , 2013, JAMA internal medicine.

[15]  P. Angus,et al.  Low testosterone levels as an independent predictor of mortality in men with chronic liver disease , 2012, Clinical endocrinology.

[16]  Howard S. Smith,et al.  Opioid-induced androgen deficiency (OPIAD). , 2012, Pain physician.

[17]  P. Morris,et al.  Testosterone and cardiovascular disease in men. , 2012, Asian journal of andrology.

[18]  G. Jackson,et al.  Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes , 2011, Diabetes Care.

[19]  S. Morgan,et al.  Individual and Contextual Determinants of Regional Variation in Prescription Drug Use: An Analysis of Administrative Data from British Columbia , 2010, PloS one.

[20]  G. B. Phillips.  Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.

[21]  V. Montori,et al.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[22]  Amy T. Wang,et al.  Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.

[23]  S. Rathore,et al.  Influence of Patient Race on Physician Prescribing Decisions: A Randomized On-Line Experiment , 2009, Journal of General Internal Medicine.

[24]  G. Hankey,et al.  Lower testosterone levels predict incident stroke and transient ischemic attack in older men. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  R. Foley,et al.  Prevalence of hypogonadism in male patients with renal failure , 2006, Postgraduate Medical Journal.

[26]  G. Stimmel,et al.  Sexual Dysfunction and Psychotropic Medications , 2006, CNS Spectrums.

[27]  D. Vasudevan,et al.  Alcohol abuse-duration dependent decrease in plasma testosterone and antioxidants in males. , 2006, Indian journal of physiology and pharmacology.

[28]  A. Lenzi,et al.  Effects of testosterone on sexual function in men: results of a meta‐analysis , 2005, Clinical endocrinology.

[29]  John F. Hurdle,et al.  Measuring diagnoses: ICD code accuracy. , 2005, Health services research.

[30]  D. Kivlahan,et al.  Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. , 2005, The Journal of clinical psychiatry.

[31]  K. Ensrud,et al.  Opioid Osteoporosisn [1] (multiple letters) , 2004 .

[32]  P. Jobanputra.  Structural and symptomatic efficacy of glucosamine and chondroitin: relevant financial interest? , 2004, Archives of internal medicine.

[33]  Jarvis T. Chen,et al.  Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: The Public Health Disparities Geocoding Project (US) , 2003, Journal of epidemiology and community health.

[34]  J. Mckinlay,et al.  Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. , 2000, Diabetes care.

[35]  A. Dobs.  Androgen therapy in AIDS wasting. , 1998, Bailliere's clinical endocrinology and metabolism.

[36]  B. Chipps,et al.  Reduction of serum testosterone levels during chronic glucocorticoid therapy. , 1986, Annals of internal medicine.

[37]  H. Daniell.  Opioid osteoporosis. , 2004, Archives of internal medicine.

[38]  D. Schoenfeld,et al.  Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. , 2000, Annals of internal medicine.